GlassScriptPhysician profile
Jaron Densky
NPI 1720469380
$4,388.82
in general payments reported to CMS, 2019-2025
19 companies · $950 in 2025
The $950 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $176 · 2021: $602 · 2022: $750 · 2023: $963 · 2024: $949 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,683 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,683.04 |
| Education | $177.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,690.62 | 2021-2025 | Inspire |
| Stryker Corporation | $361.32 | 2021-2024 | Clarifix Cryotherapy Device |
| Genzyme Corporation | $236.78 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $177.98 | 2024-2025 | |
| Smith+Nephew, INC. | $175.60 | 2020 | |
| Glaxosmithkline, LLC. | $130.91 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $120.17 | 2022-2025 | Libtayo, Dupixent |
| Aerin Medical INC. | $117.83 | 2023-2025 | |
| Olympus America INC. | $82.61 | 2022-2025 | Olympus, Evis Exera III Bronchovideoscope, Hd Camera Head |
| Neurent Medical Limited | $62.83 | 2022-2025 | Neuromark System, Neuromark Radiofrequency Console |
| Acclarent, INC | $55.38 | 2023 | Acclarent Aera, Acclarent Navwire |
| Convatec INC. | $36.89 | 2024 | |
| Hikma Pharmaceuticals USA | $34.15 | 2024 | Ryaltris |
| Hologic Sales and Service, LLC | $23.49 | 2023 | Coolseal Generator |
| Intersect Ent, INC. | $18.10 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $17.19 | 2024 | Acclarent Aera |
| Amgen INC. | $17.00 | 2025 | Tezspire |
| Optinose US, INC. | $16.47 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaron Densky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.